These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26541674)

  • 21. Initial combination therapy with desmopressin, solifenacin, and alarm for monosymptomatic nocturnal enuresis.
    Fujinaga S; Nishizaki N; Ohtomo Y
    Pediatr Int; 2017 Mar; 59(3):383-384. PubMed ID: 28317303
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of nocturia in men with desmopressin].
    Mühlstädt S
    Urologe A; 2018 Apr; 57(4):458-462. PubMed ID: 29492635
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical observations of the effect of antidiuretic hormone on nocturia in elderly men.
    Ho DR; Lin WY; Wu CF; Shee JJ; Huang YC; Chen CS
    BJU Int; 2005 Dec; 96(9):1310-3. PubMed ID: 16287451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seizures and coma after desmopressin for nocturnal enuresis.
    Passi GR; Shad R
    Indian Pediatr; 2004 Dec; 41(12):1276-7. PubMed ID: 15623917
    [No Abstract]   [Full Text] [Related]  

  • 25. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
    Van de Walle J; Van Herzeele C; Raes A
    Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: A systematic review of the efficacy and safety of desmopressin for nocturia in adults: M. H. Ebell, T. Radke and J. Gardner J Urol 2014;192:829-835.
    Nørgaard JP; Juul KV; Gupta J
    J Urol; 2015 May; 193(5):1729; discussion 1730. PubMed ID: 25660473
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of indomethacin on desmopressin resistant nocturnal polyuria and nocturnal enuresis.
    Kamperis K; Rittig S; Bower WF; Djurhuus JC
    J Urol; 2012 Nov; 188(5):1915-22. PubMed ID: 22999686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk of hyponatremia with desmopressin use for nocturnal polyuria.
    Choi EY; Park JS; Kim YT; Park SY; Kim GH
    Am J Nephrol; 2015; 41(3):183-90. PubMed ID: 25871541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of desmopressin for treatment of nocturia: a systematic review and meta-analysis of double-blinded trials.
    Zong H; Yang C; Peng X; Zhang Y
    Int Urol Nephrol; 2012 Apr; 44(2):377-84. PubMed ID: 21898039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study.
    van Kerrebroeck P; Rezapour M; Cortesse A; Thüroff J; Riis A; Nørgaard JP
    Eur Urol; 2007 Jul; 52(1):221-9. PubMed ID: 17280773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of the enuresis alarm and desmopressin: second line treatment for nocturnal enuresis.
    Kamperis K; Hagstroem S; Rittig S; Djurhuus JC
    J Urol; 2008 Mar; 179(3):1128-31. PubMed ID: 18206924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term desmopressin response in primary nocturnal enuresis: open-label, multinational study.
    Lottmann H; Baydala L; Eggert P; Klein BM; Evans J; Norgaard JP
    Int J Clin Pract; 2009 Jan; 63(1):35-45. PubMed ID: 19125991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized comparison of long-term desmopressin and alarm treatment for bedwetting.
    Evans J; Malmsten B; Maddocks A; Popli HS; Lottmann H;
    J Pediatr Urol; 2011 Feb; 7(1):21-9. PubMed ID: 20579938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial.
    Weiss JP; Zinner NR; Klein BM; Nørgaard JP
    Neurourol Urodyn; 2012 Apr; 31(4):441-7. PubMed ID: 22447415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desmopressin resistant nocturnal polyuria secondary to increased nocturnal osmotic excretion.
    Dehoorne JL; Raes AM; van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2006 Aug; 176(2):749-53. PubMed ID: 16813935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maximal bladder capacity is a positive predictor of response to desmopressin treatment in patients with MS and nocturia.
    Zahariou A; Karamouti M; Karagiannis G; Papaioannou P
    Int Urol Nephrol; 2008; 40(1):65-9. PubMed ID: 17610036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidiuresis therapy: mechanism of action and clinical implications.
    Nørgaard JP; Hashim H; Malmberg L; Robinson D
    Neurourol Urodyn; 2007; 26(7):1008-13. PubMed ID: 17480030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic options in childhood nocturnal enuresis.
    Zaffanello M; Giacomello L; Brugnara M; Fanos V
    Minerva Urol Nefrol; 2007 Jun; 59(2):199-205. PubMed ID: 17571056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Desmopressin for nocturia in the old: an inappropriate treatment due to the high risk of side-effects?].
    ten Doesschate T; Reichert LJ; Claassen JA
    Tijdschr Gerontol Geriatr; 2010 Dec; 41(6):256-61. PubMed ID: 21229778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical practice. Evaluation and management of enuresis.
    Robson WL
    N Engl J Med; 2009 Apr; 360(14):1429-36. PubMed ID: 19339722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.